Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
ublituximab
×
Clear all
Filters
3
NCT02612311
2024-12-13
UNITY-CLL
TG Therapeutics, Inc.
Phase 3
Terminated
603 enrolled
17 charts
NCT02301156
2022-05-20
GENUINE
TG Therapeutics, Inc.
Phase 3
Completed
126 enrolled
18 charts